Increases in the availability of prescribed opioids in a Canadian setting

Por Nosyk, B., Marshall, B.D.L., Fischer, B., Montaner, J.S.G., Wood, E., Kerr, T.
Publicado em 2012

HIV knowledge and perceptions of risk in a young, urban, drug-using population

Por Johnston, C.L., Marshall, B.D.L., Qi, J., Power, C.J., Kerr, T., Montaner, J.S.G., Wood, E.
Publicado em 2011

Performance of HIV-1 Drug Resistance Testing at Low-Level Viremia and Its Ability to Predict Future Virologic Outcomes and Viral Evolution in Treatment-Naive Individuals

Por Gonzalez-Serna, A., Min, J. E., Woods, C., Chan, D., Lima, V. D., Montaner, J. S. G., Harrigan, P. R., Swenson, L. C.
Publicado em 2014

Comparison of Costs of Strategies for Measuring Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma by Using Amplicor and Ultra Direct Assays

Por Raboud, J. M., Seminari, E., Rae, S. L., Harrigan, P. R., Hogg, R. S., Conway, B., Sherlock, C., Schechter, M. T., O’Shaughnessy, M. V., Montaner, J. S. G.
Publicado em 1998

HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era

Por Rodrigo, J. A., Hicks, L. K., Cheung, M. C., Song, K. W., Ezzat, H., Leger, C. S., Boro, J., Montaner, J. S. G., Harris, M., Leitch, H. A.
Publicado em 2012

Effects of Anticoagulant, Processing Delay, and Assay Method (Branched DNA versus Reverse Transcriptase PCR) on Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Pl...

Por Kirstein, Lynn M., Mellors, John W., Rinaldo, Charles R., Margolick, Joseph B., Giorgi, Janis V., Phair, John P., Dietz, Edith, Gupta, Phalguni, Sherlock, Christopher H., Hogg, Robert, Montaner, J. S. G., Muñoz, Alvaro
Publicado em 1999